LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis

ANRIL regulates production of extracellular matrix proteins and vasoactive factors in diabetic complications

(2018) Anu Alice Thomas et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

LncRNA NEAT1/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway

(2018) Fei Liu et al.   CANCER BIOLOGY & THERAPY

Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathway

(2018) Bin Zhao et al.   Cancer Biomarkers

Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2 -mutated myeloproliferative neoplasms

(2017) Chih-Cheng Chen et al.   HAEMATOLOGICA

Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma

(2017) Yandan Wang et al.   JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY

Critical role of HMGA proteins in cancer cell chemoresistance

(2017) Daniela D’Angelo et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression

(2017) Antonio Agostini et al.   Oncotarget

Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in JAK2 -mutated myeloproliferative neoplasms

(2017) Chih-Cheng Chen et al.   HAEMATOLOGICA

Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells

(2017) Dongya Zhang et al.   Scientific Reports

RETRACTED ARTICLE: Long noncoding RNA ANRIL is activated by hypoxia-inducible factor-1α and promotes osteosarcoma cell invasion and suppresses cell apoptosis upon hypoxia

(2016) Xiaokang Wei et al.   Cancer Cell International

The loss of Ezh2 drives the pathogenesis of myelofibrosis and sensitizes tumor-initiating cells to bromodomain inhibition

(2016) Goro Sashida et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value

(2016) D. Meseure et al.   MOLECULAR CANCER RESEARCH

Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells

(2016) WEI-GUANG LAN et al.   ONCOLOGY REPORTS

Expressions of miR-30c and let-7a are inversely correlated with HMGA2 expression in squamous cell carcinoma of the vulva

(2016) Antonio Agostini et al.   Oncotarget

Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer

(2015) JUN-JUN QIU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2

(2015) Ming-de Huang et al.   Journal of Hematology & Oncology

Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer

(2015) Rosemary D. Cress et al.   OBSTETRICS AND GYNECOLOGY

The Dimerization State of the Mammalian High Mobility Group Protein AT-Hook 2 (HMGA2)

(2015) Lorraine Frost et al.   PLoS One

Identification and Initial Functional Characterization of a Human Vascular Cell–Enriched Long Noncoding RNA

(2014) Robert D. Bell et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways

(2014) Wei Shen et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

ANRIL inhibits p15INK4b through the TGFβ1 signaling pathway in human esophageal squamous cell carcinoma

(2014) Deyu Chen et al.   CELLULAR IMMUNOLOGY

Long Noncoding RNA ANRIL Promotes Non-Small Cell Lung Cancer Cell Proliferation and Inhibits Apoptosis by Silencing KLF2 and P21 Expression

(2014) F.-q. Nie et al.   MOLECULAR CANCER THERAPEUTICS

Effects of HMGA2 on malignant degree, invasion, metastasis, proliferation and cellular morphology of ovarian cancer cells

(2014) Yan-Ni Xi et al.   Asian Pacific Journal of Tropical Medicine

Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3

(2013) Purnachandra Nagaraju Ganji et al.   ANGIOGENESIS

Tumor hypoxia and metabolism – Towards novel anticancer approaches

(2013) Johanna Chiche et al.   ANNALES D ENDOCRINOLOGIE

Noscapine sensitizes chemoresistant ovarian cancer cells to cisplatin through inhibition of HIF-1α

(2011) Wenjing Su et al.   CANCER LETTERS

Long Noncoding RNA, Polycomb, and the Ghosts Haunting INK4b-ARF-INK4a Expression

(2011) F. Aguilo et al.   CANCER RESEARCH

MicroRNA let-7a: A potential marker for selection of paclitaxel in ovarian cancer management

(2011) Lingeng Lu et al.   GYNECOLOGIC ONCOLOGY

Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP-Mediated Expression of HMGA2

(2010) S. Dangi-Garimella et al.   CANCER RESEARCH

ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS

(2010) Eric Pasmant et al.   FASEB JOURNAL

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The role of let-7 in cell differentiation and cancer

(2009) Benjamin Boyerinas et al.   ENDOCRINE-RELATED CANCER

Clinical Significance of High Mobility Group A2 in Human Gastric Cancer and Its Relationship to let-7 MicroRNA Family

(2008) K. Motoyama et al.   CLINICAL CANCER RESEARCH

HMGA2 gene is a promising target for ovarian cancer silencing therapy

(2008) Anastasia Malek et al.   INTERNATIONAL JOURNAL OF CANCER

The let-7 family of microRNAs

(2008) Sarah Roush et al.   TRENDS IN CELL BIOLOGY